Large-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Russia's president Vladimir Putin has appointed a little known company to manage assets linked to major German pharmaceutical ...

Two European-headquartered drugmakers told Reuters this week they are sending as much of their medicines across the Atlantic ...

Amid a raft of federal changes cutting funding and capacities at the Food and Drug Administration, investors are soon ...

Drugmakers are lobbying Trump to phase in tariffs on imported pharmaceutical products in hopes of reducing the sting from the ...

Major pharmaceutical companies reap most of their profits in the U.S. but shift their tax burdens to low-tax havens such as ...

The U.S. pharmaceutical industry is bracing for a possible wave of tariffs on foreign-made drugs, even as they received a short-term exemption this week under President Donald Trump’s sweeping new ...

MADRID (Reuters) -Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it ...

US pharmaceutical industry faces uncertainty with potential tariffs, impacting companies and healthcare costs, awaiting ...